|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses (notes 11, 15, 16) | ||||
| General and administration (note 15) | ||||
| Research and development (note 15) | ||||
| Loss before other income (expenses) | ||||
| Interest income (note 6) | ||||
| Gain (loss) on foreign exchange | ||||
| Change in derivative liability (note 9) | ||||
| Other income | ||||
| Net loss and comprehensive loss for the year | ||||
| Basic net loss per share (in CAD per share) | ||||
| Diluted net loss per share (in CAD per share) | ||||
| Weighted average number of common shares outstanding, basic | ||||
| Weighted average number of common shares outstanding, diluted |
Loading...
